Literature DB >> 1776437

The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants.

Y T Tsai1, C C Chou, K H Hsieh.   

Abstract

To study the influence of hypoallergenic milk on the occurrence of allergic diseases, thirty-three high risk, normal full-term newborns were divided into two groups with comparable family allergy score (FAS) and cord serum IgE. Group A consisted of 18 babies fed since birth with regular formula, while group B included 15 babies fed breast milk and/or NAN H.A. (Hypoallergenic infant formula) for the first 6 months of life. Close clinical observations for the appearance of atopic dermatitis, allergic rhinitis and wheezing as well as serial examination of total serum IgE and milk-specific IgE antibodies were done during the first year of life. The results showed: 1) Infants fed regular formula had a higher incidence of moderate to severe atopic dermatitis (AD) and allergic rhinitis (AR) than those fed NAN H.A. (39% vs 13% for AD; and 33% vs 13% for AR), but the difference was not significant. There was no difference in the incidence of wheezing between these two groups; 2) There was no relationship between cord blood IgE and FAS; 3) Neither the cord blood IgE nor FAS influenced the occurrence of allergic diseases and total serum IgE at one year of age; 4) Hypoallergenic milk (NAN H.A.) could support normal growth and development. In conclusion, a higher incidence of moderate to severe AD and AR was found in high risk infants fed regular formula than in those fed hypoallergenic milk. However, a study with a larger number of babies and a longer period of follow-up is needed to obtain a solid conclusion.

Entities:  

Mesh:

Year:  1991        PMID: 1776437

Source DB:  PubMed          Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi        ISSN: 0001-6578


  6 in total

Review 1.  Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies.

Authors:  Eric L Simpson; Laura E Keck; Joanne R Chalmers; Hywel C Williams
Journal:  J Allergy Clin Immunol       Date:  2012-03-15       Impact factor: 10.793

Review 3.  A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis.

Authors:  Hania Szajewska; Andrea Horvath
Journal:  World Allergy Organ J       Date:  2017-07-26       Impact factor: 4.084

4.  Infant formulas containing hydrolysed protein for prevention of allergic disease.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

Review 5.  Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis.

Authors:  Robert J Boyle; Despo Ierodiakonou; Tasnia Khan; Jennifer Chivinge; Zoe Robinson; Natalie Geoghegan; Katharine Jarrold; Thalia Afxentiou; Tim Reeves; Sergio Cunha; Marialena Trivella; Vanessa Garcia-Larsen; Jo Leonardi-Bee
Journal:  BMJ       Date:  2016-03-08

6.  Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis.

Authors:  Jacqueline Castenmiller; Karen-Ildico Hirsch-Ernst; John Kearney; Helle Katrine Knutsen; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Dominique Turck; Marco Vinceti; Rosangela Marchelli; Henk van Loveren; Céline Dumas; Ariane Titz; Stefaan de Henauw
Journal:  EFSA J       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.